Clinical Trial Update: Prevention of Gastric Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 trial, sponsored by AstraZeneca, evaluating prevention of NSAID-associated gastric ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcers
• Nsaid-induced Gastric Ulcers

Snippet

Sponsor: AstraZeneca | Conditions: NSAID Associated Gastric Ulcers | Phase 3 | Status: COMPLETED